How much does Brigatinib/Brigatinib (Brigatinib) targeted drug cost?

Brigatinib/Brigatinib (Brigatinib) is a drug used to treat non-small cell lung cancer (NSCLC) and is a tyrosine kinase inhibitor. It is mainly used to treat adult patients with NSCLC that has a positive translocation of kinase or is resistant to second-generation kinase inhibitor treatment.

Brigatinib/Brigatinib has been launched in China and has been included in medical insurance. Since it has just been approved for marketing, patients may not be able to buy it in domestic pharmacies. If you need to purchase it in China, please consult the local pharmacy. However, the price is quite high, more than 10,000 yuan. Foreign Brigatinib/Brigatinib are mainly generic drugs, mainly Bangladeshi and Laos generic drugs. The price of the international version of the Bangladeshi generic drug Yaopin is about 2000yuan, the specification is 90mg*30 tablets; the price of the Laos version of the generic drug is about 600, and the specification is smaller. And the ingredients of domestic original drugs and foreign generic drugs are basically the same.

Brigatinib/Common adverse reactions of brigatinib include nausea, vomiting, diarrhea, fatigue, headache, hypertension, pneumonia, tachycardia, and abnormal liver function. Serious adverse reactions may include interstitial lung disease, hyperglycemia, cardiotoxicity, etc. Patients should monitor closely while taking the medication and report any discomfort to their doctor.

Brigatinib/BrigatinibDuring treatment, patients should pay attention to risks such as pneumonia, hypertension, and abnormal liver function. Pneumonia in particular can be a serious side effect, and patients should be aware of symptoms related to respiratory infections and seek medical attention promptly. In addition, Brigatinib/Brigatinib may cause harm to the fetus. Pregnant and lactating women should consult a doctor before taking the drug.